Breakthrough cancer medicine and its impact on novel drug development in China: report of the US Chinese Anti-Cancer Association (USCACA) and Chinese Society of Clinical Oncology (CSCO) Joint Session at the 17th CSCO Annual Meeting

The US Chinese Anti-Cancer Association (USCACA) teamed up with Chinese Society of Clinical Oncology (CSCO) to host a joint session at the17th CSCO Annual Meeting on September 20th, 2014 in Xiamen, China. With a focus on breakthrough cancer medicines, the session featured innovative approaches to eva...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Chin J Cancer
Main Authors: Luo, Feng Roger, Ding, Jian, Chen, Helen X., Liu, Hao, Fung, Man-Cheong, Koehler, Maria, Armand, Jean Pierre, Jiang, Lei, Xu, Xiao, Zhang, Ge, Xu, Li, Qian, Pascal, Yan, Li
Formato: Artigo
Idioma:Inglês
Publicado: Sun Yat-sen University Cancer Center 2014
Assuntos:
News
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4308658/
https://ncbi.nlm.nih.gov/pubmed/25418191
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5732/cjc.014.10246
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares